Washington, March 19 : The panoramic camera on NASA’s Mars rover Opportunity has caught a first glimpse on the horizon of the uplifted rim of the big crater that has been Opportunity’s long-term destination for six months.

Opportunity’s twin, Spirit, also has a challenging destination, and last week switched to a different route for making progress.

Washington, March 19 : Scientists at The University of Nottingham have found that a biological pathway plays a role in the development of a type of brain tumour that predominantly occurs in children, and presently has a very poor prognosis.

Working on behalf of the Children's Cancer and Leukaemia Group (CCLG), the researchers have found that the WNT biological pathway is "activated" in over one-third of the cases of central nervous system primitive neuroectodermal tumours (CNS PNET).

Washington, March 19 : With the aid of a new method developed by scientists in Germany, the output frequency of the atomic fountains clocks has become more stable.

At present, Caesium fountain clocks are the most accurate clocks in the world, furnishing the second accurate to 15 places after the decimal point.

Until they reach this accuracy, caesium fountain clocks, however, need a certain measurement time.

This time has now been considerably reduced with the aid of a new method developed at the Physikalisch-Technische Bundesanstalt (PTB), which makes the output frequency of the caesium fountains more stable.

For excitation of the caesium atoms, the PTB physicists make use of a novel microwave source.

Washington, Mar 19 : Actor Justin Long has been roped in to play the lead in a romantic comedy titled ''Going the Distance''.

The plot of the film revolves around a man and woman in a long-distance relationship, who ultimately come to the realization that they would be happier dating someone closer to home, reports Variety magazine.

Director Nanette Burstein will helm the project.

Adam Shankman and Jennifer Gibgot are producing the film via their Offspring Entertainment shingle.

Washington, Mar 19: Scientists from University of Michigan School of Kinesiology have identified a potential therapeutic target for controlling high blood sugar levels.

The researchers have come across certain proteins that could lead to new drug therapies.

Understanding these proteins may also help in devising more effective exercise to prevent Type 2 diabetes, and such other health problems as are associated with having high blood sugar.

Washington, Mar 19: A drug used to treat patients with glaucoma, a condition that raises the pressure inside the eye and can cause blindness, is now being marketed to make eyelashes longer, darker and thicker.

US pharmaceutical firm Allergan, which also markets popular wrinkle treatment Botox, is the company behind the drug, Latisse.

It uses the same formula as glaucoma drug Lumigan after scientists noticed the anti-blindness treatment boosted lashes.

"This is a new innovation for lashes. Latisse fulfills a significant and previously unmet aesthetic need in the marketplace," Discovery News quoted Frederick Beddingfield, Chief Medical Officer for Allergan, as saying.